Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study

Ian W. Flinn, Manish Patel, Yasuhiro Oki, Steven Horwitz, Francine F. Foss, Kerstin Allen, Mark Douglas, Howard Stern, Jennifer Sweeney, Jahnavi Kharidia, Patrick Kelly, Virginia M. Kelly, Brad Kahl

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study'. Together they form a unique fingerprint.

Medicine & Life Sciences